Portfolio company
Drug anything
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops microarrays for molecular interaction data partnerships to enable machine learning-based drug discovery for pharmaceutical and biotechnology partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Phenomic AI
This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.
Pragma Biosciences
This company develops a drug discovery platform using machine learning to identify microbiome-derived small molecules for pharmaceutical and healthcare partners.
Technology-enabled pharmaceutical company
This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.
Relation
This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners and its own pipeline of medicines.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
Arrepath
This company develops oral small-molecule drugs for the pharmaceutical industry using artificial intelligence and machine learning workflows.
